Drug development is time consuming, expensive with high failure rates. It takes 10-15 years for a drug to go from discovery to approval, while the mean cost of developing a drug is $1.5 billions dollars. Pharmacometric models (PM) play a pivotal role in knowledge driven drug development and these models require validation prior to application. The purpose of the current study was to evaluate the posterior predictive check (PPC) and the bootstrap as population model validation tools. PPC was evaluated to determine, if it was able to distinguish between population pharmacokinetic (PPK) models that were developed/estimated from influence data versus models that were not derived/estimated from influence data. Bootstrap was examined to see if th...
Population pharmacokinetic (PopPK) models of posaconazole have been established to promote the preci...
Low likelihood-of-approval rates of new drugs constitute a major problem in clinical development. On...
Background: Observational data sets can be used for population pharmacokinetic (PK) modeling. Howeve...
Drug development is time consuming, expensive with high failure rates. It takes 10-15 years for a dr...
It has been recommended by the FDA and others that the population pharmacokinetic models (PPKM) need...
<p>(<b>a</b>) Visual predicive check (VPC) of the pharmacokinetic behavior using the posterior distr...
It was the objective of the current study to evaluate the ability of 10-fold crossvalidation and pre...
Model evaluation is an important issue in population analyses. We aimed to perform a systematic revi...
Pharmacometric model-based analysis using nonlinear mixed-effects models (NLMEM) has to date mainly ...
WOS: 000372521500008PubMed ID: 27000291Background and objective: Non-compartmental analysis (NCA) ca...
AbstractBackground and objectiveNon-compartmental analysis (NCA) calculates pharmacokinetic (PK) met...
International audienceBootstrap methods are used in many disciplines to estimate the uncertainty of ...
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2003.Includes bibliographical...
Pharmacometric modelling is an increasingly used method for analysing the outcome from clinical tria...
Population pharmacokinetic (PopPK) models of posaconazole have been established to promote the preci...
Low likelihood-of-approval rates of new drugs constitute a major problem in clinical development. On...
Background: Observational data sets can be used for population pharmacokinetic (PK) modeling. Howeve...
Drug development is time consuming, expensive with high failure rates. It takes 10-15 years for a dr...
It has been recommended by the FDA and others that the population pharmacokinetic models (PPKM) need...
<p>(<b>a</b>) Visual predicive check (VPC) of the pharmacokinetic behavior using the posterior distr...
It was the objective of the current study to evaluate the ability of 10-fold crossvalidation and pre...
Model evaluation is an important issue in population analyses. We aimed to perform a systematic revi...
Pharmacometric model-based analysis using nonlinear mixed-effects models (NLMEM) has to date mainly ...
WOS: 000372521500008PubMed ID: 27000291Background and objective: Non-compartmental analysis (NCA) ca...
AbstractBackground and objectiveNon-compartmental analysis (NCA) calculates pharmacokinetic (PK) met...
International audienceBootstrap methods are used in many disciplines to estimate the uncertainty of ...
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2003.Includes bibliographical...
Pharmacometric modelling is an increasingly used method for analysing the outcome from clinical tria...
Population pharmacokinetic (PopPK) models of posaconazole have been established to promote the preci...
Low likelihood-of-approval rates of new drugs constitute a major problem in clinical development. On...
Background: Observational data sets can be used for population pharmacokinetic (PK) modeling. Howeve...